OLMA insider trading — Olema Pharmaceuticals, Inc.
Over the last 90 days, insiders at Olema Pharmaceuticals, Inc. (OLMA) made 0 open-market purchases worth $0 and 2 open-market sales worth $291K, making them net sellers by $291K. The largest sale was by Harmon Cyrus (Director), who sold 12,500 shares for $146K on Jul 24, 2026.
Updated Oct 16, 2026.
Recent OLMA insider transactions
Every Form 4 filed by Olema Pharmaceuticals, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Jul 24, 2026 | Harmon Cyrus | Director | S · Sale | Direct | 12,500 | $11.71 | $146K | Form 4 |
| Jul 23, 2026 | Harmon Cyrus | Director | S · Sale | Direct | 12,500 | $11.58 | $145K | Form 4 |
OLMA insider trading FAQ
Are insiders buying OLMA stock?
Not on the open market. In the last 90 days, Olema Pharmaceuticals, Inc. insiders made no open-market purchases, and 2 open-market sales totaling $291K. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading OLMA?
Recent sellers: Harmon Cyrus.
Where does OLMA insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.